glioblastoma
4 stories tagged "glioblastoma"
The Glioblastoma Trial No Drug Company Paid For Posted an 82% Six-Month Progression-Free Rate
Calgary oncologists bought controlled-release niacin at retail, added it to standard treatment, and cleared their own preset bar with room to spare. The trial is small, single-arm and untidy on paper, and it was paid for entirely with grant money.
CancerGlioblastoma Craves Sugar. Oregon State Coated a Gene Therapy in It and Rode Straight Past the Blood-Brain Barrier.
Glioblastoma overexpresses the same sugar transporter that guards the brain. Oregon State researchers used that greed to smuggle a tumor-suppressor gene into tumors, and mouse survival rose 50 percent.
CancerTwenty Years of Nothing on Brain Cancer, and the Best New Lead Is a Vitamin Nobody Can Patent
A University of Calgary trial added high-dose niacin to standard glioblastoma treatment and reported 82% of 24 patients progression-free at six months. The design is single-arm and early, but the molecule is a cheap, unpatentable vitamin.
CancerFor Twenty Years, a Vitamin B12 Cancer Drug Has Worked in Mice, Dogs, and Rats. It Still Hasn't Reached a Human Trial.
Nitrosylcobalamin crossed the blood-brain barrier and pooled in a rat's brain tumor. This study didn't shrink one, the synergy ran in a petri dish, and the scientist behind the headlines holds the patents.